Patents by Inventor Silke Middendorf

Silke Middendorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of homoeriodictyol (HED) for reducing the gastric acid secretion-stimulating effect of n-acetyl-4-aminophenol (Paracetamol)
    Patent number: 11013714
    Abstract: The present invention primarily relates to the use of Homoeriodictyol (HED) or a salt thereof or a mixture of HED and one or more salts thereof or a mixture of several salts thereof for reducing the gastric acid secretion-stimulating effect of N-Acetyl-4-aminophenol (Paracetamol).
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 25, 2021
    Assignee: SYMRISE AG
    Inventors: Joachim Hans, Jakob Peter Ley, Susanne Paetz, Silke Middendorf, Kathrin Liszt, Veronika Somoza
  • THE USE OF HOMOERIODICTYOL (HED) FOR REDUCING THE GASTRIC ACID SECRETION-STIMULATING EFFECT OF N-ACETYL-4-AMINOPHENOL (PARACETAMOL)
    Publication number: 20190091199
    Abstract: The present invention primarily relates to the use of Homoeriodictyol (HED) or a salt thereof or a mixture of HED and one or more salts thereof or a mixture of several salts thereof for reducing the gastric acid secretion-stimulating effect of N-Acetyl-4-aminophenol (Paracetamol).
    Type: Application
    Filed: April 19, 2017
    Publication date: March 28, 2019
    Inventors: Joachim HANS, Jakob Peter LEY, Susanne PAETZ, Silke MIDDENDORF, Kathrin LISZT, Veronika SOMOZA
  • Pharmaceutical compositions
    Patent number: 9675568
    Abstract: Suggested is a pharmaceutical composition, comprising menthane carboxylic acid-N-(4-methoxy-phenyl)-amide.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: June 13, 2017
    Assignee: Symrise AG
    Inventors: Gerhard Krammer, Sven Siegel, Silke Middendorf
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140134113
    Abstract: Suggested is a pharmaceutical composition, comprising menthane carboxylic acid-N-(4-methoxy-phenyl)-amide.
    Type: Application
    Filed: November 8, 2013
    Publication date: May 15, 2014
    Applicant: Symrise AG
    Inventors: Gerhard Krammer, Sven Siegel, Silke Middendorf